BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, June 19, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Earnings for Jan. 31, 2020

Jan. 31, 2020
Quarterly snapshots from biopharma companies with marketed products, including: Amgen.
Read More

In the clinic for Jan. 30, 2020

Jan. 30, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Genetesis, Profusa, Righteye, Venturemed
Read More

Regulatory actions for Jan. 30, 2020

Jan. 30, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Bionik, Medtronic, Sony
Read More

Appointments and advancements for Jan. 30, 2020

Jan. 30, 2020
New hires and promotions in the med-tech industry, including: Collagen Matrix, Generex Biotechnology, Medin Technologies
Read More

Other news to note for Jan. 30, 2020

Jan. 30, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcam, Applied Stemcell, Best Medical International, Bgi, Biofourmis, Conmed, Curetis, Fuzionaire Diagnostics, Healthfirst, Hollister, ImagineMIC, Microsoft, Nationshearing, Transenterix
Read More

Financings for Jan. 30, 2020

Jan. 30, 2020
Med-tech firms raising money in public or private financings, including: Emboline, Establishment Lab Holdings, Lyra Therapeutics, MRI Interventions
Read More

Earnings for Jan. 30, 2020

Jan. 30, 2020
Quarterly snapshots from biopharma companies with marketed products, including: Alexion, Biogen, Samsung Bioepis.
Read More

Regulatory actions for Jan. 30, 2020

Jan. 30, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Albireo, Aprea, Astellas, F-star, Follicum, Merakris, Proqr, Pulmatrix, Vistagen.
Read More

Other news to note for Jan. 30, 2020

Jan. 30, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaccine, Allergan, Aptinyx, BGI, Biocorrx, Cortexyme, Curetis, Dare, Evotec, Histogen, Inovio, Iteos, Theraly, Tonix.
Read More

In the clinic for Jan. 30, 2020

Jan. 30, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aptevo, Autolus, Bayer, Eli Lilly, Exscientia, Incyte, Isofol, Kedrion, Miragen, Orion, Rubius, Sanofi, SQZ, Sumitomo Dainippon.
Read More
Previous 1 2 … 1713 1714 1715 1716 1717 1718 1719 1720 1721 … 1811 1812 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing